Trial intelligence / Profile preview

Traumeel S for pain after hallux valgus surgery

NCT00279513Phase 3Completed

Sponsor
Shaare Zedek Medical Center
Start
Sep 2006
Primary completion
Dec 2007
Modality
Botanical Extract
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of Traumeel S in postoperative pain, sponsored by Shaare Zedek Medical Center. Primary endpoint: Pain Intensity at 13 days. Started Sep 2006; status: completed.

02

Drugs

Traumeel S
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00279513.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00279513.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call